aging other formularies, public and private. In analyzing the National Formulary and formulary system in this way, the committee found that it had characteristics that were sometimes more but often less restrictive than other formularies and formulary systems. The committee has used the information and analyses here to support its conclusions and recommendations. They can be found in the Executive Summary of this report, beginning with the overall conclusion that the National Formulary does not meet the committee's definition of overly restrictive. The committee hopes that the information, analyses, conclusions, and recommendations here might also guide policy evaluations by others.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement